Different anthracycline derivates for reducing cardiotoxicity in cancer patients

Different anthracycline derivates for reducing cardiotoxicity in cancer patients

Item
http://www.wikidata.org/entity/Q24244087
Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis.Moving forward with new data and approaches: a fresh look at anthracyclines in non-Hodgkin's lymphoma.Cardiovascular complications of breast cancer therapy in older adultsSIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly.Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Matters of the heart: cardiac toxicity of adjuvant systemic therapy for early-stage breast cancerRecommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.Galician consensus on management of cardiotoxicity in breast cancer: risk factors, prevention, and early intervention.Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity
P2860

Different anthracycline derivates for reducing cardiotoxicity in cancer patients

Item
http://www.wikidata.org/entity/Q24244087
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@ast
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@en
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@en-gb
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@nl
type
label
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@ast
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@en
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@en-gb
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@nl
prefLabel
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@ast
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@en
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@en-gb
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@nl
P1433
P1476
P2093
P2860
P31
P356
P577
P698
P356
P1433
P1476
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
@en
P2093
P2860
P31
P356
10.1002/14651858.CD005006.PUB2
P577
P698